Magic mushroom drug tested to shield cancer patients from Chemo's painful side effect
NCT ID NCT07227909
Summary
This study is testing whether psilocybin, the active compound in 'magic mushrooms,' can prevent or reduce the severity of nerve damage caused by chemotherapy. It will involve 83 adults with breast, colorectal, or head & neck cancer who are scheduled to receive specific chemotherapies. Participants will receive either a full dose of psilocybin, a very low dose, or standard supportive care to see which best protects against chemotherapy-induced neuropathy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSILOCYBIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.